Nygaard V, Ree AH, Dagenborg VJ, Børresen-Dale AL, Edwin B, Fretland ÅA, Grzyb K, Haugen MH, Mælandsmo GM, Flatmark K(2023) A PRRX1 Signature Identifies TIM-3 and VISTA as Potential Immune Checkpoint Targets in a Subgroup of Microsatellite Stable Colorectal Cancer Liver Metastases Cancer Res Commun, 3(2), 235-244 DOI 10.1158/2767-9764.CRC-22-0295, PubMed 36968142
Normann LS, Haugen MH, Hongisto V, Aure MR, Leivonen SK, Kristensen VN, Tahiri A, Engebraaten O, Sahlberg KK, Mælandsmo GM(2023) High-throughput screen in vitro identifies dasatinib as a candidate for combinatorial treatment with HER2-targeting drugs in breast cancer PLoS One, 18(1), e0280507 DOI 10.1371/journal.pone.0280507, PubMed 36706086
Lien VT, Kristiansen MK, Pettersen S, Haugen MH, Olberg DE, Waaler J, Klaveness J(2019) Towards dual inhibitors of the MET kinase and WNT signaling pathway; design, synthesis and biological evaluation RSC Adv, 9(63), 37092-37100 DOI 10.1039/c9ra08954c, PubMed 35539091